HYPERCHOLESTEROLAEMIA
Clinical trials for HYPERCHOLESTEROLAEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERCHOLESTEROLAEMIA trials appear
Sign up with your email to follow new studies for HYPERCHOLESTEROLAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo pill aims to supercharge cholesterol lowering
Disease control Not yet recruitingThis Phase 3 trial tests whether a new combination pill containing laroprovstat and rosuvastatin lowers LDL cholesterol better than rosuvastatin alone. About 200 adults with high cholesterol and a history of heart disease or high risk will take either the combo or a placebo plus …
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New cholesterol combo pill aims to slash bad cholesterol without prior meds
Disease control Not yet recruitingThis study tests a new pill that combines two drugs (laroprovstat and rosuvastatin) to lower LDL or 'bad' cholesterol. About 600 adults with high cholesterol who have never taken cholesterol-lowering medication will receive either the combination, one of the drugs alone, or a pla…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Are cholesterol patients getting the right care? new study aims to find out
Knowledge-focused Not yet recruitingThis study will follow about 2,500 adults in Italy who have high cholesterol and are at high risk for heart problems. Researchers want to see if their current treatments match official guidelines and how well their cholesterol is controlled over one year. The goal is to find gaps…
Matched conditions: HYPERCHOLESTEROLAEMIA
Sponsor: Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC